FDA.reportPublic FDA data

RETEVMO

Product NDC
0002-5340
11-digit product format
000025340
Labeler code
0002
Product ID
0002-5340_7481a510-805c-4f99-b6ae-7b44e70f5f55
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
selpercatinib
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Eli Lilly and Company
Application
NDA218160
Marketing category
NDA
Marketing start
2024-04-10
Substance
SELPERCATINIB
Active strength
40 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N218160-001RETEVMOSELPERCATINIB40MGTABLET / ORALRLD2024-04-10
N218160-002RETEVMOSELPERCATINIB80MGTABLET / ORALRLD2024-04-10
N218160-003RETEVMOSELPERCATINIB120MGTABLET / ORALRLD2024-04-10
N218160-004RETEVMOSELPERCATINIB160MGTABLET / ORALRLD, RS2024-04-10

Orange Book patents#

Current patent rows page 1 of 1 · 68 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N218160-001101129422037-10-10Drug substance, Drug product2024-05-09
N218160-001101371242037-10-10U-34502024-05-09
N218160-001101371242037-10-10U-39492024-05-09
N218160-001101371242037-10-10U-39502024-05-09
N218160-001101371242037-10-10U-39512024-05-09
N218160-001101728512037-10-10U-34502024-05-09
N218160-001101728512037-10-10U-39492024-05-09
N218160-001101728512037-10-10U-39502024-05-09
N218160-001101728512037-10-10U-39512024-05-09
N218160-00110112942*PED2038-04-10Pediatric extension
N218160-00110137124*PED2038-04-10Pediatric extension
N218160-00110172851*PED2038-04-10Pediatric extension
N218160-001121382502038-10-10U-34502024-12-05
N218160-001121382502038-10-10U-39492024-12-05
N218160-001121382502038-10-10U-39502024-12-05
N218160-001121382502038-10-10U-39512024-12-05
N218160-00112138250*PED2039-04-10Pediatric extension
N218160-002101129422037-10-10Drug substance, Drug product2024-05-09
N218160-002101371242037-10-10U-34502024-05-09
N218160-002101371242037-10-10U-39492024-05-09
N218160-002101371242037-10-10U-39502024-05-09
N218160-002101371242037-10-10U-39512024-05-09
N218160-002101728512037-10-10U-34502024-05-09
N218160-002101728512037-10-10U-39492024-05-09
N218160-002101728512037-10-10U-39502024-05-09
N218160-002101728512037-10-10U-39512024-05-09
N218160-00210112942*PED2038-04-10Pediatric extension
N218160-00210137124*PED2038-04-10Pediatric extension
N218160-00210172851*PED2038-04-10Pediatric extension
N218160-002121382502038-10-10U-34502024-12-05
N218160-002121382502038-10-10U-39492024-12-05
N218160-002121382502038-10-10U-39502024-12-05
N218160-002121382502038-10-10U-39512024-12-05
N218160-00212138250*PED2039-04-10Pediatric extension
N218160-003101129422037-10-10Drug substance, Drug product2024-05-09
N218160-003101371242037-10-10U-34502024-05-09
N218160-003101371242037-10-10U-39492024-05-09
N218160-003101371242037-10-10U-39502024-05-09
N218160-003101371242037-10-10U-39512024-05-09
N218160-003101728512037-10-10U-34502024-05-09
N218160-003101728512037-10-10U-39492024-05-09
N218160-003101728512037-10-10U-39502024-05-09
N218160-003101728512037-10-10U-39512024-05-09
N218160-00310112942*PED2038-04-10Pediatric extension
N218160-00310137124*PED2038-04-10Pediatric extension
N218160-00310172851*PED2038-04-10Pediatric extension
N218160-003121382502038-10-10U-34502024-12-05
N218160-003121382502038-10-10U-39492024-12-05
N218160-003121382502038-10-10U-39502024-12-05
N218160-003121382502038-10-10U-39512024-12-05
N218160-00312138250*PED2039-04-10Pediatric extension
N218160-004101129422037-10-10Drug substance, Drug product2024-05-09
N218160-004101371242037-10-10U-34502024-05-09
N218160-004101371242037-10-10U-39492024-05-09
N218160-004101371242037-10-10U-39502024-05-09
N218160-004101371242037-10-10U-39512024-05-09
N218160-004101728512037-10-10U-34502024-05-09
N218160-004101728512037-10-10U-39492024-05-09
N218160-004101728512037-10-10U-39502024-05-09
N218160-004101728512037-10-10U-39512024-05-09
N218160-00410112942*PED2038-04-10Pediatric extension
N218160-00410137124*PED2038-04-10Pediatric extension
N218160-00410172851*PED2038-04-10Pediatric extension
N218160-004121382502038-10-10U-34502024-12-05
N218160-004121382502038-10-10U-39492024-12-05
N218160-004121382502038-10-10U-39502024-12-05
N218160-004121382502038-10-10U-39512024-12-05
N218160-00412138250*PED2039-04-10Pediatric extension

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 80 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N218160-001ODE*2027-05-08
N218160-001ODE*2027-05-08
N218160-001ODE*2027-05-08
N218160-001M-3112027-09-27
N218160-001M-3122027-09-27
N218160-001PED2027-11-08
N218160-001PED2027-11-08
N218160-001PED2027-11-08
N218160-001PED2028-03-27
N218160-001PED2028-03-27
N218160-001ODE*2029-09-21
N218160-001ODE*2029-09-21
N218160-001PED2030-03-21
N218160-001PED2030-03-21
N218160-001ODE*2031-05-29
N218160-001ODE*2031-05-29
N218160-001ODE*2031-05-29
N218160-001PED2031-11-29
N218160-001PED2031-11-29
N218160-001PED2031-11-29
N218160-002ODE*2027-05-08
N218160-002ODE*2027-05-08
N218160-002ODE*2027-05-08
N218160-002M-3112027-09-27
N218160-002M-3122027-09-27
N218160-002PED2027-11-08
N218160-002PED2027-11-08
N218160-002PED2027-11-08
N218160-002PED2028-03-27
N218160-002PED2028-03-27
N218160-002ODE*2029-09-21
N218160-002ODE*2029-09-21
N218160-002PED2030-03-21
N218160-002PED2030-03-21
N218160-002ODE*2031-05-29
N218160-002ODE*2031-05-29
N218160-002ODE*2031-05-29
N218160-002PED2031-11-29
N218160-002PED2031-11-29
N218160-002PED2031-11-29
N218160-003ODE*2027-05-08
N218160-003ODE*2027-05-08
N218160-003ODE*2027-05-08
N218160-003M-3112027-09-27
N218160-003M-3122027-09-27
N218160-003PED2027-11-08
N218160-003PED2027-11-08
N218160-003PED2027-11-08
N218160-003PED2028-03-27
N218160-003PED2028-03-27
N218160-003ODE*2029-09-21
N218160-003ODE*2029-09-21
N218160-003PED2030-03-21
N218160-003PED2030-03-21
N218160-003ODE*2031-05-29
N218160-003ODE*2031-05-29
N218160-003ODE*2031-05-29
N218160-003PED2031-11-29
N218160-003PED2031-11-29
N218160-003PED2031-11-29
N218160-004ODE*2027-05-08
N218160-004ODE*2027-05-08
N218160-004ODE*2027-05-08
N218160-004M-3112027-09-27
N218160-004M-3122027-09-27
N218160-004PED2027-11-08
N218160-004PED2027-11-08
N218160-004PED2027-11-08
N218160-004PED2028-03-27
N218160-004PED2028-03-27
N218160-004ODE*2029-09-21
N218160-004ODE*2029-09-21
N218160-004PED2030-03-21
N218160-004PED2030-03-21
N218160-004ODE*2031-05-29
N218160-004ODE*2031-05-29
N218160-004ODE*2031-05-29
N218160-004PED2031-11-29
N218160-004PED2031-11-29
N218160-004PED2031-11-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 68 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-1084e616aacf4f…
2026-09-14 22:38:342026-08N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-1084e616aacf4f…
2026-09-14 22:38:342026-08N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-1084e616aacf4f…
2026-09-14 22:38:342026-08N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-1084e616aacf4f…
2026-08-18 06:07:402026-07N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-10caaa826d4ba7…
2026-08-18 06:07:402026-07N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-10caaa826d4ba7…
2026-08-18 06:07:402026-07N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-10caaa826d4ba7…
2026-08-18 06:07:402026-07N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-10caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-10011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-1031067a03dcf5…
2025-08-23 18:47 UTC2025-08N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-106a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-10fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-10b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-10b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-10b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-10b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-1003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-1003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-1003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-1003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-102680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-102680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-102680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-102680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N218160-001RETEVMO40MGTABLET / ORALRLD2024-04-105bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N218160-002RETEVMO80MGTABLET / ORALRLD2024-04-105bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N218160-003RETEVMO120MGTABLET / ORALRLD2024-04-105bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N218160-004RETEVMO160MGTABLET / ORALRLD, RS2024-04-105bbf6a4d5a75…

Observed Orange Book patent history#

Patent history page 1 of 24 · 948 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N218160-001101129422037-10-10Drug substance, Drug product2024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101371242037-10-10U-34502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101371242037-10-10U-39492024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101371242037-10-10U-39502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101371242037-10-10U-39512024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101728512037-10-10U-34502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101728512037-10-10U-39492024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101728512037-10-10U-39502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001101728512037-10-10U-39512024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-00110112942*PED2038-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-00110137124*PED2038-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-00110172851*PED2038-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-001121382502038-10-10U-34502024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-001121382502038-10-10U-39492024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-001121382502038-10-10U-39512024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-001121382502038-10-10U-39502024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-00112138250*PED2039-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101129422037-10-10Drug substance, Drug product2024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101371242037-10-10U-34502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101371242037-10-10U-39492024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101371242037-10-10U-39502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101371242037-10-10U-39512024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101728512037-10-10U-34502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101728512037-10-10U-39492024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101728512037-10-10U-39502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002101728512037-10-10U-39512024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-00210112942*PED2038-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-00210137124*PED2038-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-00210172851*PED2038-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-002121382502038-10-10U-34502024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-002121382502038-10-10U-39512024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-002121382502038-10-10U-39502024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-002121382502038-10-10U-39492024-12-0584e616aacf4f…
2026-09-14 22:38:342026-08N218160-00212138250*PED2039-04-10Pediatric extension84e616aacf4f…
2026-09-14 22:38:342026-08N218160-003101129422037-10-10Drug substance, Drug product2024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-003101371242037-10-10U-34502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-003101371242037-10-10U-39492024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-003101371242037-10-10U-39502024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-003101371242037-10-10U-39512024-05-0984e616aacf4f…
2026-09-14 22:38:342026-08N218160-003101728512037-10-10U-34502024-05-0984e616aacf4f…

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 13 · 504 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-09-14 22:38:342026-08N218160-001ODE*2027-05-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2027-05-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2027-05-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-001M-3112027-09-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-001M-3122027-09-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2027-11-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2027-11-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2027-11-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2028-03-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2028-03-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2029-09-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2029-09-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2030-03-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2030-03-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2031-05-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2031-05-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001ODE*2031-05-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2031-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2031-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-001PED2031-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2027-05-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2027-05-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2027-05-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-002M-3112027-09-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-002M-3122027-09-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2027-11-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2027-11-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2027-11-0884e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2028-03-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2028-03-2784e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2029-09-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2029-09-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2030-03-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2030-03-2184e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2031-05-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2031-05-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002ODE*2031-05-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2031-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2031-11-2984e616aacf4f…
2026-09-14 22:38:342026-08N218160-002PED2031-11-2984e616aacf4f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
RETEVMO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SELPERCATINIB40 mg/1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
481381ff-cc0d-406c-b479-0f9e6be2c48aProduct name120201001

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0002-5340-60RETEVMO60 in 1 BOTTLETABLET, COATED6022

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0002-5340-60EA - Each0002-53408b4da5ca-564b-4be9-b06f-e54600150aeb12024-08-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0002-5340RETEVMO (SELPERCATINIB) CAPSULE RETEVMO (SELPERCATINIB) TABLET, COATED [ELI LILLY AND COMPANY]18Current NDC, 1 package rows20250103_7fa848ba-a59c-4144-9f52-64d090f4d828.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2679808Retevmo 120 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679812Retevmo 160 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2370170Retevmo 40 MG Oral CapsulePSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679814Retevmo 40 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2370174Retevmo 80 MG Oral CapsulePSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679816Retevmo 80 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679805selpercatinib 120 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679810selpercatinib 160 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2370164selpercatinib 40 MG Oral CapsulePSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679813selpercatinib 40 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2370172selpercatinib 80 MG Oral CapsulePSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679815selpercatinib 80 MG Oral TabletPSN7fa848ba-a59c-4144-9f52-64d090f4d82822
2679808selpercatinib 120 MG Oral Tablet [Retevmo]SBD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679812selpercatinib 160 MG Oral Tablet [Retevmo]SBD7fa848ba-a59c-4144-9f52-64d090f4d82822
2370170selpercatinib 40 MG Oral Capsule [Retevmo]SBD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679814selpercatinib 40 MG Oral Tablet [Retevmo]SBD7fa848ba-a59c-4144-9f52-64d090f4d82822
2370174selpercatinib 80 MG Oral Capsule [Retevmo]SBD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679816selpercatinib 80 MG Oral Tablet [Retevmo]SBD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679805selpercatinib 120 MG Oral TabletSCD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679810selpercatinib 160 MG Oral TabletSCD7fa848ba-a59c-4144-9f52-64d090f4d82822
2370164selpercatinib 40 MG Oral CapsuleSCD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679813selpercatinib 40 MG Oral TabletSCD7fa848ba-a59c-4144-9f52-64d090f4d82822
2370172selpercatinib 80 MG Oral CapsuleSCD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679815selpercatinib 80 MG Oral TabletSCD7fa848ba-a59c-4144-9f52-64d090f4d82822
2679808Retevmo 120 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679812Retevmo 160 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2370170Retevmo 40 MG Oral CapsuleSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679814Retevmo 40 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2370174Retevmo 80 MG Oral CapsuleSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679816Retevmo 80 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679805selpercatinib 120 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679810selpercatinib 160 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679813selpercatinib 40 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822
2679815selpercatinib 80 MG Oral TabletSY7fa848ba-a59c-4144-9f52-64d090f4d82822

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0002-5340-600000253406060 TABLET, COATED in 1 BOTTLE (0002-5340-60) 2024-04-10NoNoCurrent